Lakhanpal Rohit R, Javaheri Michael, Ruiz-Garcia Humberto, De Juan Eugene, Humayun Mark S
Microsurgery Advanced Design Laboratory, Doheny Retina Institute, Doheny Eye Institute, Department of Ophthalmology, Keck School of Medicine, University of Southern California, Los Angeles 90033, USA.
Retina. 2005 Apr-May;25(3):272-80. doi: 10.1097/00006982-200504000-00004.
To evaluate a new technique, 25-gauge transvitreal limited arteriovenous-crossing manipulation without vitrectomy (LAM), for the treatment of branch retinal vein occlusion (BRVO) complicated by macular hemorrhage and/or macular edema recalcitrant to grid laser photocoagulation.
Twelve eyes of 12 patients underwent LAM for BRVO performed by a single surgeon (M.S.H.) using the 25-gauge nitinol flexible-extendable blunt pick. The presence or absence of intraoperative reperfusion visualization, pre- and postoperative visual acuity, macular thickness as measured by optical coherence tomography, intraocular pressure, and lens status were evaluated.
Restoration of blood flow was noted in all patients and was based on intraoperative reestablishment of a red column of erythrocytes through the previously closed vessel. Mean visual acuity improved from 20/200 (logarithm of the minimal angle of resolution [LogMAR] +/- SD, 1.00 +/- 0.32) preoperatively to 20/70 (LogMAR +/- SD, 0.56 +/- 0.28) (P = 0.0003) at the final visit. Eleven (92%) of 12 eyes had >or=2 lines of visual improvement. Five eyes (45%) had final visual acuity of 20/50 or better. Mean macular thickness +/- SD improved from 401.0 +/- 73.2 to 178.7 +/- 19.6 microm (P < 0.0001) at the final visit. No statistically significant difference was noted in cataract progression or intraocular pressure. Mean follow-up +/- SD was 49.9 +/- 19.6 weeks. All patients were observed for at least 12 weeks.
LAM may achieve outcomes comparable with those of arteriovenous adventitial sheathotomy for complicated BRVO.
评估一种新技术,即25G经玻璃体有限动静脉交叉操作术(LAM),该技术无需玻璃体切除术,用于治疗伴有黄斑出血和/或对格栅激光光凝治疗无效的黄斑水肿的视网膜分支静脉阻塞(BRVO)。
12例患者的12只眼由同一位外科医生(M.S.H.)使用25G镍钛诺可弯曲钝头器械进行BRVO的LAM手术。评估术中是否有再灌注可视化、术前和术后视力、光学相干断层扫描测量的黄斑厚度、眼压和晶状体状态。
所有患者均观察到血流恢复,这基于术中通过先前闭塞的血管重新建立红细胞的红色柱。平均视力从术前的20/200(最小分辨角对数[LogMAR]±标准差,1.00±0.32)提高到末次随访时的20/70(LogMAR±标准差,0.56±0.28)(P = 0.0003)。12只眼中有11只(92%)视力提高了≥2行。5只眼(45%)最终视力达到20/50或更好。末次随访时,平均黄斑厚度±标准差从401.0±73.2微米改善至178.7±19.6微米(P < 0.0001)。白内障进展或眼压方面未观察到统计学上的显著差异。平均随访时间±标准差为49.9±19.6周。所有患者均至少观察了12周。
对于复杂性BRVO,LAM可能取得与动静脉外膜鞘切开术相当的治疗效果。